Rise Advisors, LLC Summit Therapeutics Inc. Transaction History
Rise Advisors, LLC
- $249 Million
- Q3 2025
A detailed history of Rise Advisors, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Rise Advisors, LLC holds 28 shares of SMMT stock, worth $610. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28Holding current value
$610% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
261Shares Held
90.4MCall Options Held
4.71MPut Options Held
3.17M-
Baker Bros. Advisors LP New York, NY33.7MShares$735 Million7.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.67MShares$189 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$172 Million0.0% of portfolio
-
State Street Corp Boston, MA4.02MShares$87.6 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.91MShares$85.1 Million0.01% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.39B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...